AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Gemsky-MV 2.2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Pinksky Pharmaceuticals Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Gemsky-MV 2.2 Tablet ER

Diabetol-Duo 2.2 Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer Diabetol-Duo 2.2 ER with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize its symptoms (sweating, vertigo, cephalalgia, tremors) and implement appropriate countermeasures. Maintain regular mealtimes and carry a readily available fast-acting glucose source (e.g., sweets, fruit juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential adverse effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any history of cardiovascular disease before commencing treatment; pregnancy or breastfeeding necessitates medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended under your physician's guidance.

Primary Ingredients of Gemsky-MV 2.2 Tablet ER

No text provided. Please provide the text you would like me to rephrase.

Uses of Gemsky-MV 2.2 Tablet ER

Managing Type 2 Diabetes

Major Benefits of Gemsky-MV 2.2 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Gemsky-MV 2.2 Tablet ER whole; avoid chewing, crushing, or breaking it. Consume this extended-release tablet on an empty stomach.

Common Side effects of Gemsky-MV 2.2 Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Gemsky-MV 2.2 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Gemsky-MV 2.2 Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet on an empty stomach.

How Gemsky-MV 2.2 Tablet ER works:

Extended-release Gemsky-MV 2.2 tablets contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Gemsky-MV 2.2 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gemsky-MV 2.2 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Gemsky-MV 2.2 Tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, with consequent infant harm.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The extended-release Gemsky-MV 2.2 Tablet is likely unsuitable for individuals with kidney impairment and its use should be avoided. Medical advice is recommended. Furthermore, its administration is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Gemsky-MV 2.2 Tablet ER cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Gemsky-MV 2.2 Tablet ER :

Should you forget a Gemsky-MV 2.2 Tablet ER dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gemsky-MV 2.2 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gemsky-MV 2.2 Tablet ER

Gemsky-MV 2.2 Tablet ER combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Gemsky-MV 2.2 Tablet ER may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Gemsky-MV 2.2 Tablet ER is contraindicated in patients with known allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Gemsky-MV 2.2 Tablet ER is unsafe. It can worsen hypoglycemia and raise the risk of lactic acidosis.
Gemsky-MV 2.2 Tablet ER can cause low blood sugar (hypoglycemia), leading to symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases if you miss meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Gemsky-MV 2.2 Tablet ER
106
MRP 129
17% off